| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 2665 | 2019 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1713 | 2019 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 637 | 2021 |
| Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response M Odendahl, H Mei, BF Hoyer, AM Jacobi, A Hansen, G Muehlinghaus, ... Blood 105 (4), 1614-1621, 2005 | 551 | 2005 |
| Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice BF Hoyer, K Moser, AE Hauser, A Peddinghaus, C Voigt, D Eilat, ... Journal of Experimental Medicine 199 (11), 1577-84, 2004 | 533 | 2004 |
| Long-lived autoreactive plasma cells drive persistent autoimmune inflammation F Hiepe, T Dörner, AE Hauser, BF Hoyer, H Mei, A Radbruch Nature Reviews Rheumatology 7 (3), 170-178, 2011 | 393 | 2011 |
| The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus T Alexander, R Sarfert, J Klotsche, AA Kühl, A Rubbert-Roth, HM Lorenz, ... Annals of the rheumatic diseases 74 (7), 1474-1478, 2015 | 382 | 2015 |
| Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort UM Geisen, DK Berner, F Tran, M Sümbül, L Vullriede, M Ciripoi, HM Reid, ... Annals of the rheumatic diseases 80 (10), 1306-1311, 2021 | 366 | 2021 |
| Memory B and memory plasma cells T Yoshida, H Mei, T Dörner, F Hiepe, A Radbruch, S Fillatreau, BF Hoyer Immunological reviews 237 (1), 117-139, 2010 | 359 | 2010 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 297 | 2020 |
| HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus AM Jacobi, H Mei, BF Hoyer, IM Mumtaz, K Thiele, A Radbruch, ... Annals of the rheumatic diseases 69 (01), 305-308, 2010 | 205 | 2010 |
| Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab BF Hoyer, IM Mumtaz, K Loddenkemper, A Bruns, C Sengler, ... Annals of the rheumatic diseases 71 (1), 75-79, 2012 | 184 | 2012 |
| Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 146 | 2021 |
| How do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new … M Mosca, KH Costenbader, SR Johnson, V Lorenzoni, GD Sebastiani, ... Arthritis & Rheumatology 71 (1), 91-98, 2019 | 131 | 2019 |
| EULAR/ACR classification criteria for SLE M Aringer Seminars in arthritis and rheumatism 49 (3), S14-S17, 2019 | 125 | 2019 |
| SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 124 | 2022 |
| Long‐lived plasma cells and their contribution to autoimmunity BF Hoyer, RA Manz, A Radbruch, F Hiepe Annals of the New York Academy of Sciences 1050 (1), 124-133, 2005 | 118 | 2005 |
| Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases R Hasseli, U Mueller-Ladner, BF Hoyer, A Krause, HM Lorenz, A Pfeil, ... RMD open 7 (1), e001464, 2021 | 116 | 2021 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 109 | 2021 |
| Adaptation of humoral memory T Höfer, G Muehlinghaus, K Moser, T Yoshida, H E. Mei, K Hebel, ... Immunological reviews 211 (1), 295-302, 2006 | 108 | 2006 |
Falk HiepeCharité - Universitätsmedizin Berlin & Deutsches RheumaForschungszentrum BerlinVerified email at charite.de
